GnRH antagonists

被引:51
作者
Coccia, ME [1 ]
Comparetto, C [1 ]
Bracco, GL [1 ]
Scarselli, G [1 ]
机构
[1] Univ Florence, Dept Gynaecol Perinatol & Human Reprod, I-50129 Florence, Italy
关键词
GnRH-antagonisc; ovarian hyperstimulation; assisted reproduction techniques;
D O I
10.1016/j.ejogrb.2004.01.033
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian stimulation is an important step in the success rate of in vitro fertilization (IVF) allowing multiple follicular growth, several oocytes and consequently more embryos. The combination of GnRH-antagonists (GnRH-ant) and gonadotrophins is now available for clinical use and represent a valid alternative to classical protocol with GnRH agonist. GnRH-antagonists induce a direct block of GnRH receptor with a rapid decrease in LH and FSH, preventing LH surge. Two protocols has been designed for assisted reproduction technology (ART) treatment: multiple-dose protocol and a single-dose. Both protocols are simply, efficacious, started in the late follicular phase and do not have side effects. A review of GnRH-antagonist applications in ART cycles are presented. Smaller doses of gonadotrophins, shorter stimulation period and lower ovarian hyperstimulation syndrome (OHSS) incidence are reported in literature using GnRH-antagonist compared to agonist. Triggering of ovulation, the use in polycystic ovarian syndrome (PCOS) and poor reponders patients are other interesting indication. Regarding to pregnancy rate and potentially adverse effects of drugs on endometrium or implantation needed more data. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S44 / S56
页数:13
相关论文
共 65 条
[21]   Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys [J].
Duffy, DM ;
Stewart, DR ;
Stouffer, RL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :342-349
[22]   Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers [J].
Duijkers, IJM ;
Klipping, C ;
Willemsen, WNP ;
Krone, D ;
Schneider, E ;
Niebch, G ;
Hermann, R .
HUMAN REPRODUCTION, 1998, 13 (09) :2392-2398
[23]   Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'? [J].
Engel, JB ;
Ludwig, M ;
Felberbaum, R ;
Albano, C ;
Devroey, P ;
Diedrich, K .
HUMAN REPRODUCTION, 2002, 17 (08) :2022-2026
[24]  
Fauser B C, 2000, Ned Tijdschr Geneeskd, V144, P370
[25]   GnRH-antagonists in gynecology: First results within controlled ovarian hyperstimulation (COH) [J].
Felberbaum, R ;
Reissmann, T ;
Zoll, C ;
Kupker, W ;
AlHasani, S ;
Diedrich, C ;
Diedrich, K .
GYNAKOLOGISCH-GEBURTSHILFLICHE RUNDSCHAU, 1995, 35 :113-117
[26]   Ovarian stimulation for in-vitro fertilization intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: agonists and antagonists [J].
Felberbaum, R ;
Diedrich, K .
HUMAN REPRODUCTION, 1999, 14 :207-221
[27]   PRESERVED PITUITARY-RESPONSE UNDER OVARIAN STIMULATION WITH HMG AND GNRH ANTAGONISTS (CETRORELIX) IN WOMEN WITH TUBAL INFERTILITY [J].
FELBERBAUM, RE ;
REISSMANN, T ;
KUPKER, W ;
BAUER, O ;
ALHASANI, S ;
DIEDRICH, C ;
DIEDRICH, K .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1995, 61 (02) :151-155
[28]   Ganirelix [J].
Gillies, PS ;
Faulds, D ;
Balfour, JAB ;
Perry, CM .
DRUGS, 2000, 59 (01) :107-111
[29]   INHIBITION OF LUTEINIZING-HORMONE, FOLLICLE-STIMULATING-HORMONE AND SEX-STEROID LEVELS IN MEN AND WOMEN WITH A POTENT ANTAGONIST ANALOG OF LUTEINIZING-HORMONE-RELEASING HORMONE, CETRORELIX (SB-75) [J].
GONZALEZBARCENA, D ;
BUENFIL, MV ;
PROCEL, EG ;
GUERRAARGUERO, L ;
CORNEJO, IC ;
COMARUSCHALLY, AM ;
SCHALLY, AV .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 131 (03) :286-292
[30]   Gonadotropin-releasing hormone antagonists - Implications for oocyte quality and uterine receptivity [J].
Gordon, K .
HUMAN FERTILITY AND REPRODUCTION: THE OOCYTE, THE EMBRYO, AND THE UTERUS, 2001, 943 :49-54